Tislelizumab in People With Colorectal Cancer

Clinical trial NCT06529523 · RECRUITING

Trial details

NCT number: NCT06529523
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2024-07-26
Primary completion: 2028-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.